Novel inhibitor of 70S ribosome by obstructing the peptide exit tunnel

Self-assembling peptide, forming a hydrogel matrix to support growth of cells in the presence of an ionic solution, enhancing chondrogenic differentiation of bone marrow stromal cells (BMSCs)

Novel NF-κB inhibitor and lipopolysaccharide (LPS)-induced nitric oxide production inhibitor

Potent D3 receptor antagonist with high 5-HT1A receptor affinity

Novel specific inhibitor of MYC

Novel TRPV1 antagonist

Novel ROS1 kinase inhibitor

Novel ROS1 kinase inhibitor

Novel potent and selective inhibitor of kir1.1 channels

Novel inducer of the ISG54 promoter, causing IRF-3 translocation

Novel Max-binding modulator, attenuating Myc-driven transcription and stabilizing the Max homodimer

Novel KIF18A inhibitor, causing significant mitotic arrest in vivo, binding at the interface of KIF18A and tubulin

Novel FGFR2 inhibitor, enhancing the chemosensitivity of drug-resistant gastric cancer cell lines

Novel anti-inflammatory and antioxidant agent, significantly decreasing blood glucose, triglycerides, and cholesterol and increased insulin

Inhibitor of Aβ-induced inflammation

Novel Pim-1 kinase Inhibitor, dose-dependent decreasing the viability of LS174T and HCT-116 cells

Novel potent peptide dual agonist of opioid/neurokinin 1 receptor

Novel and potent factor Xa inhibitor

Potent and selective adenosine A1 antagonist with renal protective and diuretic activities

Phosphate acceptor peptide substrate for cAMP-dependent protein kinase

Potent and selective KDM5 inhibitor

Potent and selective KDM5 inhibitor

Novel KDM4 inhibitor

Novel selective KDM4C inhibitor

Potent PDZ domain peptide inhibitor that rescues CFTR activity

Novel potent and Subtype-Selective Positive Modulator of KCa2 Channels

Dual PDE3/4 inhibitor

Highly specific transglutaminase 2 (TG2) inhibitor

LTB4 inhibitor for the treatment of b-cell leukemias and lymphomas, potently inhibiting histamine, platelet activating factor,and 5-lipoxygenase

Novel ADAM12 and MMP inhibitor, ameliorating cardiac function in a transverse aortic constriction (TAC) model by inhibiting the proteolytic activation of HB-EGF signaling, exerting its antidiabetic effect by ameliorating insulin sensitivity through the in